Ravi C Dara Shares WHO’s Phase A guidance for PBM from ISBT
Ravi C Dara, Consultant Physician Transfusion medicine at Sheikh Shakhbout Medical City, reposted from ISBT on LinkedIn:
”Better outcomes, fewer transfusions – Optimizing outcomes while reducing transfusions – WHO‘s Phase A guidance is here”
Quoting International Society of Blood Transfusion (ISBT)‘s post:
”The Patient Blood Management subgroup of the ISBT Clinical Transfusion Working Party is dedicated to spreading awareness on PBM and to help support its wider implementation.
This week, we’re shining a light on Patient Blood Management (PBM) and each day, we’ll explore a different phase of the PBM system, sharing diverse perspectives on who can benefit from it.
Patient blood management (PBM) is a new paradigm to manage and preserve an individual’s own blood in health and illness and highlighted as a patient-centered approach aimed at improving patient outcomes with reduced morbidity, mortality and length of hospital stay.
For Day 1, we’re highlighting Phase A of the WHO Implementation Guidance, focusing on the aims and initial steps involved in establishing PBM within healthcare settings.”
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 22:03Erin VanDyke: A Journey Through VTE Leadership and Healthcare Transformation
-
Jun 23, 2026, 21:19Ahmed Koriesh: Join Us for Future of Stroke Care 2026
-
Jun 23, 2026, 20:30Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV